Literature DB >> 27088607

The Integration of Emotional, Physiologic, and Communication Responses to Medical Oncology Surveillance Appointments During Breast Cancer Survivorship.

Margaret F Clayton1, Catherine Dingley, Gary Donaldson.   

Abstract

BACKGROUND: Breast cancer survivors regularly interact with providers during routine surveillance medical oncology visits, discussing uncertainty and anxiety about potential cancer recurrence for many years after treatment. Physiologic alteration can also occur as a stress response, triggered by an upcoming surveillance visit. Survivor-provider communication can theoretically allay emotional distress.
OBJECTIVE: The aim of this study was to evaluate associations between emotional (uncertainty, anxiety, concerns about recurrence) and physiologic responses (cytokine levels, lymphocyte counts), and survivor-provider communication (women's plans for their visit, negotiation of decision-making roles).
METHODS: Twenty-seven community-dwelling breast cancer survivors participated. Blood specimens, and self-reported data focusing on the previous month, were collected immediately before and the morning after a regularly scheduled medical oncology visit.
RESULTS: Global concerns about cancer recurrence and acute anxiety and uncertainty were associated with changes in immune status before and after the visit. Postvisit natural killer cells increased in 70% of women, and uncertainty/anxiety decreased. Thirty-three percent of women reported a previous minor illness. Most women had a visit plan; 66% successfully negotiated decision-making roles with providers.
CONCLUSIONS: Triggered by an upcoming medical oncology visit, women experience uncertainty, anxiety, and altered immunity, potentially placing them at risk of disease exacerbations. IMPLICATIONS FOR PRACTICE: Not all women respond similarly to a routine surveillance visit; thus, providers must determine who may be at increased risk of emotional distress and physiologic alteration. Survivor-provider communication facilitates immediate resolution of concerns. Explanations of symptom meaning reduce anxiety and uncertainty and by extension may help resolve immune alteration. Between visits, this could be done by nurse-operated telephone-based "help lines."

Entities:  

Mesh:

Year:  2017        PMID: 27088607      PMCID: PMC5559203          DOI: 10.1097/NCC.0000000000000375

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  32 in total

1.  Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up.

Authors:  D Palli; A Russo; C Saieva; S Ciatto; M Rosselli Del Turco; V Distante; P Pacini
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

Review 2.  Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors--a systematic review of quantitative studies.

Authors:  L Koch; L Jansen; H Brenner; V Arndt
Journal:  Psychooncology       Date:  2012-01-10       Impact factor: 3.894

Review 3.  It takes nerve to tell T and B cells what to do.

Authors:  Nicholas W Kin; Virginia M Sanders
Journal:  J Leukoc Biol       Date:  2006-03-10       Impact factor: 4.962

Review 4.  The integration of cardiovascular behavioral medicine and psychoneuroimmunology: new developments based on converging research fields.

Authors:  Willem J Kop
Journal:  Brain Behav Immun       Date:  2003-08       Impact factor: 7.217

5.  Communication with breast cancer survivors.

Authors:  Margaret F Clayton; William N Dudley; Adrian Musters
Journal:  Health Commun       Date:  2008

6.  Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry.

Authors:  Suzanne C Segerstrom; Gregory E Miller
Journal:  Psychol Bull       Date:  2004-07       Impact factor: 17.737

7.  Cortisol levels and responses to mammography screening in breast cancer survivors: a pilot study.

Authors:  Laura S Porter; Merle Mishel; Virginia Neelon; Michael Belyea; Etta Pisano; Mary Scott Soo
Journal:  Psychosom Med       Date:  2003 Sep-Oct       Impact factor: 4.312

8.  Increased emotional distress in daughters of breast cancer patients is associated with decreased natural cytotoxic activity, elevated levels of stress hormones and decreased secretion of Th1 cytokines.

Authors:  Miri Cohen; Ehud Klein; Abraham Kuten; Geta Fried; Oren Zinder; Shimon Pollack
Journal:  Int J Cancer       Date:  2002-07-20       Impact factor: 7.396

9.  Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer.

Authors:  Michael H Antoni; Suzanne Lechner; Alain Diaz; Sara Vargas; Heather Holley; Kristin Phillips; Bonnie McGregor; Charles S Carver; Bonnie Blomberg
Journal:  Brain Behav Immun       Date:  2008-09-20       Impact factor: 7.217

10.  Impact of Event Scale: a measure of subjective stress.

Authors:  M Horowitz; N Wilner; W Alvarez
Journal:  Psychosom Med       Date:  1979-05       Impact factor: 4.312

View more
  3 in total

1.  Communication Training: Needs Among Oncology Nurses Across the Cancer Continuum.

Authors:  Elaine Wittenberg; Joy Goldsmith; Haley Buller; Sandra L Ragan; Betty Ferrell
Journal:  Clin J Oncol Nurs       Date:  2019-02-01       Impact factor: 1.027

Review 2.  Communicating with Patients and Families Around Difficult Topics in Cancer Care Using the COMFORT Communication Curriculum.

Authors:  Elaine Wittenberg; Anne Reb; Elisa Kanter
Journal:  Semin Oncol Nurs       Date:  2018-08-09       Impact factor: 2.315

3.  Perspective of Uncertainty and Emotional Responses in Breast Cancer Patients During the COVID-19 Pandemic.

Authors:  Lilik Supriati; I Ketut Sudiana; Hanik Endang Nihayati; Muhammad Rodli; Rinik Eko Kapti
Journal:  SAGE Open Nurs       Date:  2022-09-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.